Related Experiment Video
Updated: May 8, 2026

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
Glanders: an overview of infection in humans
Kristopher E Van Zandt1, Marek T Greer, H Carl Gelhaus
1Battelle, 505 King Ave, Columbus, OH 43201-2693, USA. cgelhaus@mriglobal.org.
Abstract:
Glanders is a highly contagious and often fatal zoonotic disease, primarily of solipds. In the developed world, glanders has been eradicated. However, prior use of B. mallei as a biological weapon and its high mortality in inhalation animal studies has affirmed B. mallei as a biodefense concern. This threat requires the development of new glanders medical countermeasures (MCMs), as there is a lack of an effective vaccine and lengthy courses of multiple antibiotics needed to eradicate B. mallei. Here, we present a literature review of human glanders in which we discuss the clinical epidemiology and risk factors, potential routes of exposure, symptoms, the incubation period, and specific diagnostics. This review focuses on pulmonary glanders, as this is the most likely outcome of a biological weapons attack. Additionally, we outline current treatment regimens and propose a clinical definition of human pulmonary glanders infection.
Insights
Glanders, a dangerous zoonotic disease caused by B. mallei, is a biodefense concern due to its potential as a biological weapon. This review details human glanders, focusing on pulmonary infection and medical countermeasures.
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Biodefense
Background:
- Glanders is a highly contagious, fatal zoonotic disease primarily affecting equids.
- Eradicated in developed nations, B. mallei remains a biodefense concern due to its potential use as a biological weapon.
- Current medical countermeasures are insufficient, lacking effective vaccines and requiring lengthy antibiotic treatments.
Purpose of the Study:
- To conduct a literature review on human glanders.
- To focus on pulmonary glanders as the most probable outcome of a biological weapon attack.
- To outline current treatment regimens and propose a clinical definition for human pulmonary glanders.
Main Methods:
- Literature review of human glanders cases and research.
- Analysis of clinical epidemiology, risk factors, and exposure routes.
- Examination of diagnostic methods, symptoms, and incubation periods.
Main Results:
- Human glanders presents with diverse clinical manifestations.
- Pulmonary glanders is the most likely form following a biological weapon release.
- Effective vaccines are lacking, and treatment requires prolonged antibiotic therapy.
Conclusions:
- Human glanders, particularly pulmonary infection, poses a significant biodefense threat.
- Development of novel medical countermeasures, including vaccines, is critical.
- Standardized clinical definitions and diagnostic approaches are needed for effective management.
More Related Videos
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
11:14Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Reservoir of Infection
Infectious Diseases and Their Occurrence
Endocarditis I: Introduction